Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dingkundan oral liquid for primary dysmenorrhea (cold coagulation and blood stasis type)
ChiCTR2100045204Phase 4Recruiting
- Sponsor
- Xiyuan Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dingkundan in primary dysmenorrhea (PD) (3 arms), sponsored by Xiyuan Hospital. Primary endpoint: Degree of abdominal pain during menstruation (VAS score). Started Dec 2020; status: recruiting.
02
Drugs
dingkundan
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on ChiCTR2100045204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045204.